Search: onr:"swepub:oai:DiVA.org:uu-405339" >
Hyaluronan derived ...
-
Jones, Julia M.UCL, Div Surg & Intervent Sci, London, England;Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England
(author)
Hyaluronan derived nanoparticle for simvastatin delivery : evaluation of simvastatin induced myotoxicity in tissue engineered skeletal muscle
- Article/chapterEnglish2020
Publisher, publication year, extent ...
-
2020
-
ROYAL SOC CHEMISTRY,2020
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-405339
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-405339URI
-
https://doi.org/10.1039/c9bm00986hDOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Statins are currently the most prescribed hypercholesterolemia-lowering drugs worldwide, with estimated usage approaching one-sixth of the population. However, statins are known to cause pleiotropic skeletal myopathies in 1.5% to 10% of patients and the mechanisms by which statins induce this response, are not fully understood. In this study, a 3D collagen-based tissue-engineered skeletal muscle construct is utilised as a screening platform to test the efficacy and toxicity of a new delivery system. A hyaluronic acid derived nanoparticle loaded with simvastatin (HA-SIM-NPs) is designed and the effect of free simvastatin and HA-SIM-NPs on cellular, molecular and tissue response is investigated. Morphological ablation of myotubes and lack of de novo myotube formation (regeneration) was evident at the highest concentrations (333.33 mu M), independent of delivery vehicle (SIM or HA-SIM-NP). A dose-dependent disruption of the cytoskeleton, reductions in metabolic activity and tissue engineered (TE) construct tissue relaxation was evident in the free drug condition (SIM, 3.33 mu M and 33.33 nM). However, most of these changes were ameliorated when SIM was delivered via HA-SIM-NPs. Significantly, homogeneous expressions of MMP2, MMP9, and myogenin in HA-SIM-NPs outlined enhanced regenerative responses compared to SIM. Together, these results outline statin delivery via HA-SIM-NP as an effective delivery mechanism to inhibit deleterious myotoxic side-effects.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Player, Darren J.UCL, Div Surg & Intervent Sci, London, England
(author)
-
Samanta, SumantaTampere Univ, Fac Med & Hlth Technol, Bioengn & Nanomed Lab, Tampere 33720, Finland;Tampere Univ, BioMediTech Inst, Tampere 33720, Finland
(author)
-
Rangasami, Vignesh K.Tampere Univ, Fac Med & Hlth Technol, Bioengn & Nanomed Lab, Tampere 33720, Finland;Tampere Univ, BioMediTech Inst, Tampere 33720, Finland
(author)
-
Hilborn, Jöns,1956-Uppsala universitet,Polymerkemi(Swepub:uu)johil255
(author)
-
Lewis, Mark P.Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England
(author)
-
Oommen, Oommen P.Tampere Univ, Fac Med & Hlth Technol, Bioengn & Nanomed Lab, Tampere 33720, Finland;Tampere Univ, BioMediTech Inst, Tampere 33720, Finland
(author)
-
Mudera, VivekUCL, Div Surg & Intervent Sci, London, England
(author)
-
UCL, Div Surg & Intervent Sci, London, England;Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, EnglandUCL, Div Surg & Intervent Sci, London, England
(creator_code:org_t)
Related titles
-
In:Biomaterials Science: ROYAL SOC CHEMISTRY8:1, s. 302-3122047-48302047-4849
Internet link
Find in a library
To the university's database